(Reuters) - UK-listed drugmaker Indivior Plc said on Tuesday it would cut about 130 jobs after lowering its profit forecast for the year, hurt by continued adverse market dynamics impacting the near-term net revenue for its Sublocade treatment, used to treat opioid-related disorders.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sonia Cheema)